Krystal Biotech buy Cantor Fitzgerald
Start price
29.08.24
/
50%
€182.70
Target price
29.08.25
-
Performance (%)
-31.50%
End price
30.08.25
€125.15
Summary
This prediction ended on 30.08.25 with a price of €125.15. The BUY prediction by Cantor_Fitzgerald for Krystal Biotech performed very badly with a performance of -31.50%. Cantor_Fitzgerald has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 3.678% | 3.678% | 33.718% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Krystal Biotech
Stopped prediction by Cantor_Fitzgerald for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€105.00
13.12.23
13.12.23
€166.84
13.12.24
13.12.24
47.38%
14.12.24
14.12.24
Krystal Biotech
Start price
Target price
Perf. (%)
€103.00
07.11.23
07.11.23
€149.84
07.11.24
07.11.24
75.83%
08.11.24
08.11.24